KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Amneal Pharmaceuticals (AMRX) Return on Assets (2018 - 2025)

Amneal Pharmaceuticals has reported Return on Assets over the past 8 years, most recently at 0.04% for Q4 2025.

  • Quarterly results put Return on Assets at 0.04% for Q4 2025, up 6.0% from a year ago — trailing twelve months through Dec 2025 was 0.04% (up 6.0% YoY), and the annual figure for FY2025 was 0.04%, up 6.0%.
  • Return on Assets for Q4 2025 was 0.04% at Amneal Pharmaceuticals, up from 0.02% in the prior quarter.
  • Over the last five years, Return on Assets for AMRX hit a ceiling of 0.04% in Q4 2025 and a floor of 0.07% in Q1 2023.
  • Median Return on Assets over the past 5 years was 0.0% (2021), compared with a mean of 0.02%.
  • Biggest five-year swings in Return on Assets: grew 8bps in 2021 and later decreased -8bps in 2022.
  • Amneal Pharmaceuticals' Return on Assets stood at 0.01% in 2021, then tumbled by -1400bps to 0.07% in 2022, then surged by 79bps to 0.01% in 2023, then tumbled by -56bps to 0.02% in 2024, then soared by 266bps to 0.04% in 2025.
  • The last three reported values for Return on Assets were 0.04% (Q4 2025), 0.02% (Q3 2025), and 0.02% (Q2 2025) per Business Quant data.